Grants per year
Personal profile
Training Experience
| 2000 | Postdoctoral Fellowship, Leukemia Research Foundation |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Microbiology, PhD, University of Tokyo
… → 1993
Fingerprint
Dive into the research topics where Masato Ikeda is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 5 Finished
-
Abemaciclib treatment for EBV-associated lymphoma
Longnecker, R. M. (PD/PI) & Ikeda, M. (Other)
3/10/20 → 3/9/22
Project: Research project
-
The CDK4/6 Inhibitor Abemaciclib (LY2835219) for the Treatment of EBV-Associated Lymphomas
Longnecker, R. M. (PD/PI) & Ikeda, M. (Other)
1/27/16 → 1/27/18
Project: Research project
-
EBV and Innate Immunity in HIV+ and Normal Oral Epithelium
Longnecker, R. M. (PD/PI) & Ikeda, M. (Other)
Case Western Reserve University, National Institute of Dental and Craniofacial Research
9/1/12 → 4/30/14
Project: Research project
-
Biochemical and Genetic Studies of Latent Membrane Pro 2
Longnecker, R. M. (PD/PI) & Ikeda, M. (Co-PD/PI)
7/1/03 → 4/30/08
Project: Research project
-
Biochemical and Genetic Studies of Latent Membrane Pro 2
Longnecker, R. M. (PD/PI) & Ikeda, M. (Co-PD/PI)
7/1/03 → 4/30/08
Project: Research project
-
Latent membrane proteins from EBV differentially target cellular pathways to accelerate MYC-induced lymphomagenesis
Ikeda, M., Hayes, C. K., Schaller, S. J. & Longnecker, R., Jul 26 2022, In: Blood Advances. 6, 14, p. 4283-4296 14 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Rewiring of B cell receptor signaling by Epstein-Barr virus LMP2A
Fish, K., Comoglio, F., Shaffer, A. L., Ji, Y., Pan, K. T., Scheich, S., Oellerich, A., Doebele, C., Ikeda, M., Schaller, S. J., Nguyen, H., Muppidi, J., Wright, G. W., Urlaub, H., Serve, H., Staudt, L. M., Longnecker, R. & Oellerich, T., Oct 20 2020, In: Proceedings of the National Academy of Sciences of the United States of America. 117, 42, p. 26318-26327 10 p.Research output: Contribution to journal › Article › peer-review
Open Access43 Scopus citations -
Two pathways of p27kip1 degradation are required for murine lymphoma driven by myc and EBV latent membrane protein 2A
Sora, R. P., Ikeda, M. & Longnecker, R., Mar 1 2019, In: mBio. 10, 2, e00548-19.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
EBV latent membrane protein 2A orchestrates p27kip1 degradation via Cks1 to accelerate MYC-driven lymphoma in mice
Fish, K., Sora, R. P., Schaller, S. J., Longnecker, R. & Ikeda, M., Dec 7 2017, In: Blood. 130, 23, p. 2516-2526 11 p.Research output: Contribution to journal › Article › peer-review
Open Access23 Scopus citations -
The c-Cbl proto-oncoprotein downregulates EBV LMP2A signaling
Ikeda, M. & Longnecker, R., Mar 1 2009, In: Virology. 385, 1, p. 183-191 9 p.Research output: Contribution to journal › Article › peer-review
Open Access19 Scopus citations